Cargando…
Comparison of Two Site-Specifically (18)F-Labeled Affibodies for PET Imaging of EGFR Positive Tumors
[Image: see text] The epidermal growth factor receptor (EGFR) serves as an attractive target for cancer molecular imaging and therapy. Our previous positron emission tomography (PET) studies showed that the EGFR-targeting affibody molecules (64)Cu-DOTA-Z(EGFR:1907) and (18)F-FBEM-Z(EGFR:1907) can di...
Autores principales: | Su, Xinhui, Cheng, Kai, Jeon, Jongho, Shen, Bin, Venturin, Gianina Teribele, Hu, Xiang, Rao, Jianghong, Chin, Frederick T., Wu, Hua, Cheng, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218868/ https://www.ncbi.nlm.nih.gov/pubmed/24972326 http://dx.doi.org/10.1021/mp5003043 |
Ejemplares similares
-
PET of HER2 Expression with a Novel (18)FAl Labeled Affibody
por: Xu, Yuping, et al.
Publicado: (2017) -
Thiol-Reactive PODS-Bearing Bifunctional Chelators for the Development of EGFR-Targeting [(18)F]AlF-Affibody Conjugates
por: Da Pieve, Chiara, et al.
Publicado: (2020) -
Molecular design of radiocopper-labelled Affibody molecules
por: Tolmachev, Vladimir, et al.
Publicado: (2018) -
The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule
por: Garousi, Javad, et al.
Publicado: (2017) -
Affibody Molecules as Targeting Vectors for PET Imaging
por: Tolmachev, Vladimir, et al.
Publicado: (2020)